Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy

This study is currently recruiting participants.
Verified December 2011 by Seoul National University Hospital
Sponsor:
Information provided by (Responsible Party):
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01485939
First received: November 28, 2011
Last updated: December 5, 2011
Last verified: December 2011
  Purpose

The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores after operation compared with placebo patch in patients undergoing laparoscopic cholecystectomy.


Condition Intervention Phase
Postoperative, Pain
Other: placebo patch applied
Other: 5% lidocaine patch
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • post operative pain after laparoscopic cholecystectomy [ Time Frame: post operative periods ] [ Designated as safety issue: No ]
    We will measure intensity of pain(numeric rating scale)at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours.


Secondary Outcome Measures:
  • pain controlled drug doses in postoperative periods. [ Time Frame: postoperative periods ] [ Designated as safety issue: No ]
    We will measure doses of pain controlled drug(opioid, NSAIDS) at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours.


Estimated Enrollment: 80
Study Start Date: November 2011
Estimated Study Completion Date: May 2012
Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: placebo patch Other: placebo patch applied
Patients in this group would applied the placebo patch after laparoscopic cholecystectomy.
Active Comparator: lidocaine patch Other: 5% lidocaine patch
Patients in this group would applied the 5% lidocaine patch after laparoscopic cholecystectomy.

Detailed Description:
  • The 5% lidocaine patch have been approved for the treatment of postherpetic neuralgia.
  • The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores, pain controlled drug(opioids, NSAID) in post operative period.
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients of ASA Ⅰ-Ⅱ
  • aged 18~65
  • scheduled to undergo elective laparoscopic cholecystectomy under general anesthesia.

Exclusion Criteria:

  • patients with chronic pain
  • patients with taking regular analgesics
  • patients with allergy to ketorolac or lidocaine
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01485939

Contacts
Contact: Eunjoo Choi, MD 82-31-787-6572 ejchoi7956@gmail.com

Locations
Korea, Republic of
Seoul national university Bundang hospital Recruiting
Seongnam, Kyoung-ki-do, Korea, Republic of, 463-707
Contact: Eunjoo Choi, MD     82-31-787-6572     ejchoi7956@gmail.com    
Principal Investigator: Pyung Bok Lee, MD, PhD            
Sponsors and Collaborators
Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01485939     History of Changes
Other Study ID Numbers: Laparo_cholecystectomy_lidotop
Study First Received: November 28, 2011
Last Updated: December 5, 2011
Health Authority: Korea: Institutional Review Board

Keywords provided by Seoul National University Hospital:
lidocaine patch
laparoscopic cholecystectomy

Additional relevant MeSH terms:
Lidocaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses
Anti-Arrhythmia Agents
Cardiovascular Agents

ClinicalTrials.gov processed this record on June 17, 2013